News & Updates

Local intranasal treatment with budesonide does not appear to be effective for persistent hyposmia in patients with nonsevere COVID-19, according to a study.

Dr Jamalul Azizi Abdul Rahaman, a consultant pulmonologist (respiratory physician) at Sultan Idris Shah Serdang Hospital, and Dr Tinku Joseph, chief of Interventional Pulmonology at Amrita Institute of Medical Sciences in India, edited a book titled “A Case-Based Approach to Interventional Pulmonology: A Focus on Asian Perspectives.” The book was launched in conjunction with the 9th Asian Pacific Congress on Bronchology and Interventional Pulmonology, held at Le Meridien Hotel, Putrajaya, in May 2023. Here, they provide a summary of the book and answer questions posed by MIMS Doctor.

A cross-sectional analysis has found an association between insomnia, poor sleep quality, and extremes of sleep duration and increased COVID-19 infection and hospitalization.

In the treatment of patients with programmed cell death ligand 1 (PD-L1)-positive, unresectable, and locally advanced nonsmall cell lung cancer (NSCLC), the use of durvalumab immunotherapy in combination with curative radiotherapy yields survival gains with tolerable adverse events (AEs), as shown in the results of the phase II DOLPHIN trial.

Perioperative nivolumab plus platinum-based chemotherapy improves pathological complete response (pCR) rate and survival outcomes vs neoadjuvant platinum-based chemotherapy alone in patients with resectable stage IIIA/B non-small-cell lung cancer (NSCLC), results of the NADIM II trial have shown.